Hitachi and MD Anderson to collaborate in research in oropharyngeal cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Hitachi Healthcare Americas Corp. and MD Anderson Cancer Center announced an agreement to collaborate on a randomized clinical trial comparing the outcomes and side-effects of intensity-modulated proton beam therapy versus intensity-modulated photon therapy for the treatment of oropharyngeal cancer of the head and neck.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login